Clinical trials: ESBL-producing Enterobacteriaceae Infections
Enterobacteriaceae Infections
Prevalence of ESBL and CPE in French Nursing Homes
CARBEHPAD is a multicentric randomized prevalence study aiming to assess the frequency of Enterobacteriaceae (ESLB) and carbapenemase producing Enterobacteriaceae (CPE) carriage in Pays de la Loire nursing homes.
- Trial name
- CARBEHPAD (NCT03401242)
- Where
- France
- Volunteers
- 734 people, healthy volunteers welcome
- Sponsor
- Nantes University Hospital
Antibiotic Resistant Infection
Can Probiotic Vivomixx Eradicate Colonization With ESBL?
Can probiotic Vivomixx eradicate Extended Spectrum BetaLactam (ESBL) colonization in adult patients?
- Trial name
- NCT03860415
- Testing
- Vivomixx
- Where
- Sweden
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Lund University
Extended Spectrum Beta Lactamases (ESBL) E. Coli
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
This study is to identify and isolate well-defined microbials (non-ESBL E. coli) in an observational setting exploring natural gastrointestinal decolonization of humans colonized with ESBL E. coli.
- Trial name
- NCT04764500
- Testing
- examination of stool sample, patient questionnaire, examination of blood sample
- Where
- Switzerland
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland